Atlas Trials

Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)

Clinical trial NCT01994733 · COMPLETED

Trial details

NCT number
NCT01994733
Sponsor
Unity Health Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
End-stage Renal Disease
Start date
2014-01-01
Primary completion
2015-04-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.